ProVag: the effect of oral probiotics on the vaginal microbiota composition in women receiving medical assisted reproduction in a Dutch fertility clinic – protocol of a randomised, placebo-controlled, double-blind study
Open Access
Abstract
Introduction: Differences in the profile of the vaginal microbiota (VMB) have been associated with pregnancy rates after medical assisted reproduction (MAR) such as in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI). Monitoring the VMB profile of IVF patients creates an opportunity to identify the best window for IVF treatment and embryo transfer. The ReceptIVFity test is a predictive test that assesses the chances of becoming pregnant in women undergoing IVF treatment based on the VMB composition. A VMB profile dominated by beneficial strains, most notably Lactobacillus species, is associated with increased pregnancy chances. However, to date, limited evidence is available on the effect of active modification strategies to facilitate the modulation of the VMB profile to help restore a VMB dominated by Lactobacillus species. Methods and analysis: This is a randomised, placebo-controlled, double-blind intervention study. The study will involve 1:1 randomisation to one of the two arms: oral probiotic or placebo. Vaginal and rectal swabs will be collected at intake and 4, 6 and 8 weeks after the start of the treatment. Our objective is to determine if oral probiotic treatment improves the VMB profile of IVF patients from a low to a medium/high ReceptIVFity score, compared with placebo treatment. Secondary outcomes are: the potential of the bacterial strains in the oral probiotic to be detected in the vaginal tract and/or in the gut, and if the treatment leads to an increased ongoing pregnancy rate after IVF. Ethics and dissemination: Ethical approval was obtained by the local medical ethical review committee at the Maastricht University Medical Centre. Findings from this study will be published in a peer-reviewed scientific journal and presented at one or more scientific conferences. Trial registration number: CCMO NL81210.068.22, registered 25 September 2023.Keywords
This publication has 30 references indexed in Scilit:
- Association between vaginal microbiota and risk of early pregnancy miscarriageComparative Immunology, Microbiology and Infectious Diseases, 2021
- Analysis of vaginal and endometrial microbiota communities in infertile women with a history of repeated implantation failureReproductive Medicine and Biology, 2021
- The association between vaginal microbiota and female infertility: a systematic review and meta-analysisArchives of Gynecology and Obstetrics, 2020
- Effect of the vaginal microbiome on the pregnancy rate in women receiving assisted reproductive treatmentJournal of Assisted Reproduction and Genetics, 2019
- The relation of the vaginal microbiota to early pregnancy development during in vitro fertilization treatment—A meta-analysisJournal of Gynecology Obstetrics and Human Reproduction, 2019
- Study on the effects of an oral lactobacilli and lactoferrin complex in women with intermediate vaginal microbiotaArchives of Gynecology and Obstetrics, 2018
- Fecal microbiome analysis as a diagnostic test for diverticulitisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2014
- Studies on the effects of probiotic Lactobacillus mixture given orally on vaginal and rectal colonization and on parameters of vaginal health in women with intermediate vaginal floraEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2012
- The dynamics of the vaginal microbiome during infertility therapy with in vitro fertilization-embryo transferJournal of Assisted Reproduction and Genetics, 2012
- Randomized, double-blind, placebo-controlled study of oral lactobacilli to improve the vaginal flora of postmenopausal womenEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2008